CTIS.eu › Cities › Ireland › Waterford
Waterford
Ireland
42 total trials
19 recruiting
2024-512749-18-00
4
2022-03-03
Newly diagnosed Multiple Myeloma
2023-507698-16-00
5
2021-10-14
Chronic Lymphocytic Leukemia/Small
Lymphocytic Lymphoma (BRUIN CLL-322
2022-500439-35-00
5
2021-02-11
treatment-naive chronic lymphocytic leukemia
2023-510390-33-00
5
2020-10-23
HER2-negative breast cancer patients with high relapse risk after
stan
2023-509908-15-00
10
2020-01-20
Mantle Cell Lymphoma
2023-504932-16-00
5
2019-06-04
Muscle Invasive Bladder Cancer
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
2022-502937-24-00
5
2019-01-02
Atopic Dermatitis
2024-516881-12-00
5
2017-07-05
High risk resected melanoma.
2023-507889-89-00
5
2016-02-19
Respiratory tract infection
2024-514841-12-00
5
2015-10-27
To determine whether the addition of palbociclib to adjuvant endocrine
2024-516137-13-00
5
2014-12-18
Metastatic Prostate Cancer
2024-516801-22-00
5
2012-04-26
Patients with 1-3 positive Nodes, Hormone Receptor-Positive and Her2-N
2022-502380-37-00
5
2019-08-02
Open-Angle Glaucoma
2023-508832-68-00
9
2019-03-28
Recurrent or stage IVB cervical cancer
2023-508010-42-00
5
2016-09-14
Homologous recombination deficiency advanced ovarian cancer
2024-516132-10-00
4
2016-02-05
Metastatic breast cancer
2023-509137-39-00
5
2015-11-06
Stage IB (T ≥ 4 cm), II and IIIA NSCLC
Showing 25–42 of 42 trials